Publicaciones en colaboración con investigadores/as de Boston University School of Medicine (10)

2024

  1. Clinical relevance of intracranial hemorrhage after thrombectomy versus medical management for large core infarct: a secondary analysis of the SELECT2 randomized trial

    Journal of NeuroInterventional Surgery, pp. 1-8

2022

  1. A role for the circadian transcription factor NPAS2 in the progressive loss of non-rapid eye movement sleep and increased arousal during fentanyl withdrawal in male mice

    Psychopharmacology, Vol. 239, Núm. 10, pp. 3185-3200

  2. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  3. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic

    Stroke and Vascular Neurology, Vol. 6, Núm. 4, pp. 542-552

2019

  1. A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss

    Obesity, Vol. 27, Núm. 2, pp. 205-216

  2. Topical application of TGF-β-activating peptide, KRFK, prevents inflammatory manifestations in the TSP-1-deficient mouse model of chronic ocular inflammation

    International Journal of Molecular Sciences, Vol. 20, Núm. 1

2018

  1. Alteration in nerves and neurotransmitter stimulation of lacrimal gland secretion in the TSP-1-/- mouse model of aqueous deficiency dry eye article

    Mucosal Immunology, Vol. 11, Núm. 4, pp. 1138-1148

2016

  1. Conjunctival Goblet Cell Function: Effect of Contact Lens Wear and Cytokines

    Eye and Contact Lens, Vol. 42, Núm. 2, pp. 83-90

2015

  1. Inflammatory Cytokine-Mediated Regulation of Thrombospondin-1 and CD36 in Conjunctival Cells

    Journal of Ocular Pharmacology and Therapeutics, Vol. 31, Núm. 7, pp. 419-428